Neovascular AMD

Ultra-widefield optomap retinal imaging has transformed care at Rachel Cauchi Optometrists, where every patient is now screened on the device....

New five-year data on Susvimo – a refillable implant that delivers continuous ranibizumab to the eye – has shown the...

More details of a proposed $11 million-a-year ‘Neovascular AMD treatment incentive program’ that would financially encourage more ophthalmologists to bulk...

Melbourne biopharmaceutical company Opthea has abandoned efforts to develop its therapy sozinibercept for neovascular age-related macular degeneration (nAMD), with a...

Melbourne biopharmaceutical firm Opthea has failed to meet the primary end point in a pivotal Phase 3 trial of its...

The Federal Government is deferring the controversial private health insurance reclassification of intravitreal injections for another 12 months and will...

Macular Disease Foundation Australia (MDFA) is calling on the next Federal Government to allow bulk billing of eye injections for...

The Federal Government is implementing a controversial recommendation from the taskforce review into ophthalmology Medicare items that will mean macular...

Macular Disease Foundation Australia (MDFA) has launched Eye Connect, a comprehensive support service for people living with macular disease and...

A landmark trial has successfully used a radiotherapy robot system to treat neovascular age-related macular degeneration (nAMD). In the study...